Organization: Health Canada
Year: 2023
Month: July
Request Number: A-2022-001650
Request Summary: Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate which was accepted into review on or after December 1, 2022. Advise of the dosage form in which the drug in this ANDS is proposed to be sold, as described in paragraph C.08.002(2)(l) of the Food and Drug Regulations.
Disposition: Disclosed in part
Number of pages: 2